AXSOME THERAPEUTICS, INC. Operating Lease Liability
AXSOME THERAPEUTICS, INC. (AXSM) had Operating Lease Liability of $22.22 million as of 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Balance Sheet › Liabilities
us-gaap:OperatingLeaseLiability · last filed 2026-08-10
- 2026-06-30: Operating Lease, Liability $22.22M.
- 2026-03-31: Operating Lease, Liability $23.01M.
- 2025-12-31: Operating Lease, Liability $23.62M.
- 2025-09-30: Operating Lease, Liability $23.78M.
| Period end | Operating Lease, Liability | Operating Lease, Liability as first filed |
|---|---|---|
| 2026-06-30 | $22.22M 10-Q · filed 2026-08-10 | |
| 2026-03-31 | $23.01M 10-Q · filed 2026-05-04 | |
| 2025-12-31 | $23.62M 10-K · filed 2026-02-23 | |
| 2025-09-30 | $23.78M 10-Q · filed 2025-11-03 | |
| 2025-06-30 | $23.96M 10-Q · filed 2025-08-04 | |
| 2025-03-31 | $24.36M 10-Q · filed 2025-05-05 | |
| 2024-12-31 | $7.88M 10-K · filed 2025-02-18 | |
| 2024-09-30 | $8.07M 10-Q · filed 2024-11-12 | |
| 2024-06-30 | $8.25M 10-Q · filed 2024-08-05 | |
| 2024-03-31 | $8.41M 10-Q · filed 2024-05-06 | |
| 2023-12-31 | $8.30M 10-K · filed 2024-02-23 | |
| 2023-09-30 | $8.13M 10-Q · filed 2023-11-06 | |
| 2023-06-30 | $7.89M 10-Q · filed 2023-08-07 | |
| 2023-03-31 | $108.00K 10-Q · filed 2023-05-09 | |
| 2022-12-31 | $424.67K 10-K · filed 2023-02-28 | |
| 2022-09-30 | $416.88K 10-Q · filed 2022-11-07 | |
| 2022-03-31 | $709.12K 10-Q · filed 2022-08-09 | $967.25K 10-Q · filed 2022-05-02 |
| 2021-12-31 | $620.67K 10-K · filed 2022-03-01 | |
| 2021-09-30 | $880.12K 10-Q · filed 2021-11-08 | |
| 2021-06-30 | $1.17M 10-Q · filed 2021-08-09 | |
| 2021-03-31 | $1.53M 10-Q · filed 2021-05-10 | |
| 2020-12-31 | $1.80M 10-K · filed 2022-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Elanco Animal Health Inc (ELAN) | United States | $11.177B | -61.80 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |
| TG THERAPEUTICS, INC. (TGTX) | United States | $8.805B | 19.05 |
| MADRIGAL PHARMACEUTICALS, INC. (MDGL) | United States | $11.859B | -38.17 |
| BIOMARIN PHARMACEUTICAL INC (BMRN) | United States | $11.879B | 151.80 |
| Praxis Precision Medicines, Inc. (PRAX) | United States | $7.884B | -27.60 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |